Residency · Stamford, CT
Sponsored by Stamford Hospital
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
JAMA oncology · 2022 · 1,677 citations · Nazanin Rajai
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
Journal of diabetes science and technology · 2023 · 237 citations · Athena Philis-Tsimikas
Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis.
Cardiovascular diabetology · 2024 · 167 citations · Daniyal Ameen
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
JAMA · 2021 · 440 citations · Athena Philis-Tsimikas
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
Lancet (London, England) · 2021 · 351 citations · David Hsi
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
Diabetes technology & therapeutics · 2022 · 186 citations ·
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study.
JACC. Cardiovascular interventions · 2023 · 86 citations · David Lorenz
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.
The lancet. Diabetes & endocrinology · 2023 · 107 citations · Athena Philis-Tsimikas